• <b id="qfd60"></b>

    <listing id="qfd60"><source id="qfd60"></source></listing>

      1. <listing id="qfd60"></listing>
          <b id="qfd60"></b>

            <b id="qfd60"></b>

            當前位置 : Millipore >>> Millipore/05-803 | Anti-Tau (3-repeat isoform RD3) Antibody, clone 8E6/C11/05-803/200 µL
            Millipore/05-803 | Anti-Tau (3-repeat isoform RD3) Antibody, clone 8E6/C11/05-803/200 µL
            • Millipore/05-803 | Anti-Tau (3-repeat isoform RD3) Antibody, clone 8E6/C11/05-803/200 µL

            Millipore/05-803 | Anti-Tau (3-repeat isoform RD3) Antibody, clone 8E6/C11/05-803/200 µL

            價格: ¥5304.00 市場價: 8840.00

            貨號: 05-803
            品牌: Millipore
            規格
            數量
            庫存(0)
            特別 提示
            代購產品:無質量問題不接受退換貨,下單前請仔細核對信息。
            下單后請及時聯系客服核對商品價格,訂單生效后再付款。
            資深產品顧問
            咨詢顧問

            全國免費服務熱線

            4000-520-616


            • 自營商城 一站式服務
            • 廠家直采 剔除溢價
            • 品質甄選 正品保證
            • 嚴控流程 只做188精品
            • 極速物流 如約送貨
            • 詳情
            • 使用說明
            • 常見問題
              • Description
                CatalogueNumber05-803
                BrandFamilyUpstate
                TradeName
                • Upstate
                DescriptionAnti-Tau(3-repeatisoformRD3)Antibody,clone8E6/C11
                AlternateNames
                • Gproteinbeta1/gamma2subunit-interactingfactor1
                • Neurofibrillarytangleprotein
                • Pairedhelicalfilament-tau
                • microtubule-associatedproteintau
                • microtubule-associatedproteintau,isoform4.
                BackgroundInformationMicrotubuleAssociatedProteins,orMAPS,bindtothetubulinsubunitsofmicrotubulestructuresandregulatetheirfunctionalstABIlity.InthecellMAPsbindtomonomerandmultimerizedtubulin.MAPbindingtomultimerizedtubulinfurtherstabilizestheformationofhigherordermicrotubulinstructures.MAPbindingtomicrotubulestructuresismediatedthroughphosphorylationthroughMicrotubuleAffinityRegulatedKinase(MARK).PhosphorylationreleasesMAPsboundtomicrotubules,destabilizingthestructure,drivingittowarddisassembly.TherearepredominatelytwoMAPtypes,I,II.TypeIIMAPincludesMAP2,MAP4,andtauandarefoundinnervoustissue.Sixtauisoformsexistinbraintissue,andtheyaredistinguishedbytheirnumberofbindingdomains.Threeisoformshavethreebindingdomainsandtheotherthreehavefourbindingdomains.Thebindingdomainsarelocatedinthecarboxy-terminusoftheproteinandarepositively-charged(allowingittobindtothenegatively-chargedmicrotubule).Theisoformswithfourbindingdomainsarebetteratstabilizingmicrotubulesthanthosewiththreebindingdomains.
                ProductInformation
                FormatCultureSupernatant
                Control
                • Lysatesfromratbraincytosolfraction.
                PresentationMouseculturesupernatantcontaining0.05%sodiumazide.Frozenat-20°C.
                StorageandShippingInformation
                StorageConditionsStablefor1yearat-20°Cfromdateofreceipt.
                Formaximumrecoveryofproduct,centrifugethevialpriortoremovingthecap.

                HandlingRecommendations:
                Uponfirstthaw,andpriortoremovingthecap,centrifugethevialandgentlymixthesolution.Aliquotintomicrocentrifugetubesandstoreat-20°C.Avoidrepeatedfreeze/thawcycles,whichmaydamageIgGandaffectproductperformance.Note:Variabillityinfreezertemperaturesbelow-20°Cmaycauseglycerolcontainingsolutionstobecomefrozenduringstorage.
                Applications
                ApplicationAnti-Tau(3-repeatisoformRD3)Antibody,clone8E6/C11isanantibodyagainstTau(3-repeatisoformRD3)foruseinIH&WB.
                KeyApplications
                • Immunohistochemistry
                • WesternBlotting
                ApplicationNotesImmunohistochemistry:
                ThisantibodyhasbeenreportedbyanindependentlaboratorytodetectTau(3-repeatisoformRD3)inautoclavedparaffinbrainsections(deSilva,R.,2003).

                DifferentialDetectionofTauopathies:
                (Togo,T.,2002.)
                BIOLOGicalInformation
                ImmunogenBovinethyroglobulinconjugatedsyntheticpeptidecorrespondingtoaminoacids209-224(KHQPGGGKVQIVYKPV)ofhumanTau(isoformRD3).InotherisoformsofhuTauthissequencespansaminoacids267-316,omittingthesecondrepeatdomainwhereitbridgesRD1andRD3.Theimmunizingsequenceisidenticalinhuman,mouseandbovine.
                Clone8E6/C11
                ConcentrationPleaserefertotheCertificateofAnalysisforthelot-specificconcentration.
                HostMouse
                SpecificityRecognizesTau(3-repeatisoformRD3),Mr45-65kDa.HigherMWbands(68-72kDa)representphosphorylatedTau.
                IsotypeIgG
                SpeciesReactivity
                • Human
                SpeciesReactivityNoteHuman.Cross-reactivitywithmouseandbovineexpectedduetosequencehomology.
                AntibodyTypeMonoclonalAntibody
                EntrezGeneNumber
                EntrezGeneSummaryThisgeneencodesthemicrotubule-associatedproteintau(MAPT)whosetranscriptundergoescomplex,regulatedalternativesplicing,givingrisetoseveralmRNAspecies.MAPTtranscriptsaredifferentiallyexpressedinthenervoussystem,dependingonstageofneuronalmaturationandneurontype.MAPTgenemutationshavebeenassociatedwithseveralneurodegenerativedisorderssuchasAlzheimer"sdisease,Pick"sdisease,frontotemporaldementia,cortico-basaldegenerationandprogressivesupranuclearpalsy.
                GeneSymbol
                • MAPT
                • MTBT2
                • tau
                • FTDP-17
                • MSTD
                • TAU
                • MTBT1
                • PHF-tau
                • MGC138549
                • MAPTL
                • FLJ31424
                • DDPAC
                • PPND
                PurificationMethodUnpurified
                UniProtNumber
                UniProtSummaryFUNCTION:SwissProt:P10636#Promotesmicrotubuleassemblyandstability,andmightbeinvolvedintheestablishmentandmaintenanceofneuronalpolarity.TheC-terminusbindsaxonalmicrotubuleswhiletheN-terminusbindsneuralplasmamembranecomponents,suggestingthattaufunctionsasalinkerproteinbetweenboth.Axonalpolarityispredeterminedbytaulocalization(intheneuronalcell)inthedomainofthecellbodydefinedbythecentrosome.TheshortisoformsallowplasticityoftheCytoskeletonwhereasthelongerisoformsmaypreferentiallyplayaroleinitsstabilization.
                SIZE:758aminoacids;78878Da
                SUBUNIT:InteractswithPSMC2throughSQSTM1(Bysimilarity).InteractswithSQSTM1whenpolyubiquitinated.
                SUBCELLULARLOCATION:Cytoplasm,cytosol.Cellmembrane.Note=Mostlyfoundintheaxonsofneurons,inthecytosolandinassociationwithplasmamembranecomponents.
                TISSUESPECIFICITY:Expressedinneurons.IsoformPNS-tauisexpressedintheperipheralnervoussystemwhiletheothersareexpressedinthecentralnervoussystem.DEVELOPMENTALSTAGE:Four-repeat(typeII)tauisexpressedinanadult-specificmannerandisnotfoundinfetalbrain,whereasthree-repeat(typeI)tauisfoundinbothadultandfetalbrain.
                DOMAIN:SwissProt:P10636Thetau/MAPrepeatbindstotubulin.TypeIisoformscontain3repeatswhiletypeIIisoformscontain4repeats.
                PTM:PhosphorylationatserineandthreonineresiduesinS-PorT-Pmotifsbyproline-directedproteinkinases(PDPK:CDC2,CDK5,GSK-3,MAPK)(only2-3sitesperproteinininterphase,seven-foldincreaseinmitosis,andinPHF-tau),andatserineresiduesinK-X-G-SmotifsbyMAP/microtubuleaffinity-regulatingkinase(MARK)inAlzheimerdiseasedbrains.Phosphorylationdecreaseswithage.Phosphorylationwithintau"srepeatdomainorinflankingregionsseemstoreducetau"sinteractionwith,respectively,microtubulesorplasmamembranecomponents.PhosphorylationonSer-610,Ser-622,Ser-641andSer-673inseveralisoformsduringmitosis.&Polyubiquitinated.RequiresfunctionalTRAF6andmayprovokeSQSTM1-dependentdegradationbytheproteasome(Bysimilarity).PHF-taucanbemodifiedbythreedifferentformsofpolyubiquitination."Lys-48"-linkedpolyubiquitinationisthemajorform,"Lys-6"-linkedand"Lys-11"-linkedpolyubiquitinationalsooccur.&GlycationofPHF-tau,butnotnormalbraintau.Glycationisanon-enzymaticpost-translationalmodificationthatinvolvesacovalentlinkagebetweenasugarandanaminogroupofaproteinmoleculeformingketoamine.Subsequentoxidation,fragmentationand/orcross-linkingofketoamineleadstotheproductionofadvancedglycationendproducts(AGES).GlycationmayplayaroleinstabilizingPHFaggregationleADIngtotangleformationinAD.
                DISEASE:SwissProt:P10636#InAlzheimerdisease,theneuronalcytoskeletoninthebrainisprogressivelydisruptedandreplacedbytanglesofpairedhelicalfilaments(PHF)andstraightfilaments,mainlycomposedofhyperphosphorylatedformsofTAU(PHF-TAUorADP-TAU).&DefectsinMAPTareacauseoffrontotemporaldementiaandparkinsonismlinkedtochromosome17(FTDP17)[MIM:600274,172700];alsocalledfrontotemporaldementia(FTD)orhistoricallytermedPickcomplex.Thisformoffrontotemporaldementiaischaracterizedbypreseniledementiawithbehavioralchanges,deteriorationofcognitivecapacitiesandlossofmemory.Insomecases,parkinsoniansymptomsareprominent.Neuropathologicalchangesincludefrontotemporalatrophyoftenassociatedwithatrophyofthebasalganglia,substantianigra,amygdala.Inmostcases,proteintaudepositsarefoundinglialcellsand/orneurons.&DefectsinMAPTareacauseofpallido-ponto-nigraldegeneration(PPND)[MIM:168610].Theclinicalfeaturesincludeocularmotilityabnormalities,dystoniaandurinaryincontinence,besidesprogressiveparkinsonismanddementia.&DefectsinMAPTareacauseofcorticobasaldegeneration(CBD).Itismarkedbyextrapyramidalsignsandapraxiaandcanbeassociatedwithmemoryloss.NeuropathologicfeaturesmayoverlapAlzheimerdisease,progressivesupranuclearpalsy,andParkinsondisease.&DefectsinMAPTareacauseofprogressivesupranuclearpalsy(PSP)[MIM:601104,260540];alsoknownasSteele-Richardson-Olszewskisyndrome.PSPischaracterizedbyakinetic-rigidsyndrome,supranucleargazepalsy,pyramidaltractdysfunction,pseudobulbarsignsandcognitivecapacitiesdeterioration.Neurofibrillarytanglesandgliosisbutnoamyloidplaquesarefoundindiseasedbrains.Mostcasesappeartobesporadic,withasignificantassociationwithacommonhaplotypeincludingtheMAPTgeneandtheflankingregions.Familialcasesshowanautosomaldominantpatternoftransmissionwithincompletepenetrance;geneticanalysisofafewcasesshowedtheoccurrenceoftaumutations,includingadeletionofAsn-613.&DefectsinMAPTmaybeacauseofhereditarydysphasicdisinhibitiondementia(HDDD)[MIM:607485].HDDDisafrontotemporaldementiacharacterizedbyprogressivecognitivedeficitswithmemorylossandpersonalitychanges,severedysphasicdisturbancesleadingtomutism,andhyperphagia.
                SIMILARITY:Contains4Tau/MAPrepeats.
                MolecularWeight~45-65kDa;phosphorylatedformsat68-72kDa.
                PhysicochemicalInformation
                Dimensions
                MaterialsInformation
                MaterialsInformation
              售后保障
              螞蟻淘生物188,秉承螞蟻淘一貫的嚴謹態度,由螞蟻淘公司專業人員負責品控、采購、物流、銷售、售后,保障正品優質。以“快速好省,為科研提供好產品、好價格”為理念,直接鏈接原廠家,從全國各地原制造商嚴格挑選188款科研精品,剔除品牌溢價,188生物新電商,把好的產品帶給科研!? 力求給你最優質的商品。
            • Q:生物188產品正品保障嗎?
              A:生物188質量把控人員具有十年的從業經驗,在業界享有良好的口碑;自營商城,直接從廠家采購, 自己的團隊負責國際物流和清關,中間沒有第三方,所有流程嚴格把控,100%保證正品,假一罰十。

              Q:下單后可以修改訂單嗎?
              A:下單后的商品付款之前可以修改;訂單付款成功,需要聯系我們客服進行修改;客服電話:4000-520-616

              Q:可以開發票嗎?
              A:本網站所售商品都是正規清關,均開具16%正規發票,發票金額含配送費金額,另有說明的除外。

              Q:商品幾天可以發貨?
              A:生物188商品,全部現貨銷售,付款后即可發貨,一般一周內送達!

              Q:如何聯系商家?
              A:有任何問題夠可以電話咨詢我們,全國24小時免費服務熱線:4000-520-616 或聯系我們的在線客服QQ:1570468124

              Q:收到的商品少了/發錯了怎么辦?
              A:同個訂單購買多個商品可能會分為一個以上包裹發出,可能不會同時送達,建議查看訂單詳情是否是 部分發貨狀態;如未收到,可聯系在線客服或者致電4000-520-616。

              Q:退換貨/維修需要多長時間?
              A:一般情況下,退貨處理周期為客戶收到產品一個月內(以快遞公司顯示簽收時間為準),包裝規格、 數量、品種不符,外觀毀損、短缺或缺陷,請在收到貨24小時內申請退換貨;特殊商品以合同條款為準。

            何為188

            極簡而嚴謹,我們僅銷售188款生物醫學科研用品,款款都是爆款;因為少所以聚焦,聚焦甄選每一款產品,聚焦服務每一位客戶!

            關注我們 :

            點擊QQ聯系我們
            生物188微信

            關注188微信公眾號

            獲取最新優惠活動通知
            • 品質甄選,正品保證

            • 自營電商,廠家直采

            • 極簡主義,188精品

          1. <b id="qfd60"></b>

            <listing id="qfd60"><source id="qfd60"></source></listing>

              1. <listing id="qfd60"></listing>
                  <b id="qfd60"></b>

                    <b id="qfd60"></b>

                    欧美疯狂做受xxxx高潮